Necrobiosis Lipoidica

What is it?

Necrobiosis lipoidica (NL) is a rare, chronic inflammatory skin condition characterized by shiny, yellowish-brown plaques with telangiectasia (visible blood vessels) that typically appear on the shins. The condition involves degeneration of collagen in the dermis (deeper layer of skin) and is strongly associated with diabetes mellitus, occurring in approximately 0.3-1% of diabetic patients. Despite this association, about one-third of patients with necrobiosis lipoidica do not have diabetes.

Who is affected?

Necrobiosis lipoidica demonstrates specific demographic patterns:

• Age distribution: Can occur at any age but most commonly develops between 30-40 years
• Gender predilection: Women are affected 3 times more frequently than men
• Diabetes association: 60-70% of patients have diabetes mellitus (usually Type 1)
• Prevalence: Rare condition affecting approximately 0.3% of diabetic patients
• Family history: Occasional familial clustering reported

What are the clinical features?

The condition presents with characteristic skin changes:

Visual characteristics:

• Initial lesions: Small, firm, red-brown papules or nodules
• Evolved plaques: Enlarging to form irregular, well-demarcated plaques
• Central appearance: Yellow-brown, waxy, atrophic center
• Border characteristics: Raised, red-violet edge
• Surface features: Shiny, translucent appearance with visible blood vessels
• Size: Typically 1-3 cm but can become much larger

Location:

• Most common: Bilateral pretibial areas (shins) in 85% of cases
• Other sites: Forearms, hands, trunk, face (less common)
• Distribution: Often bilateral and roughly symmetrical

How is it diagnosed?

Diagnosis is primarily clinical but may require confirmation:

• Clinical examination: Recognition of characteristic yellowish plaques on shins
• Dermoscopy: Shows comma-shaped vessels and yellow structureless areas
• Skin biopsy: May be performed if diagnosis uncertain, shows palisading granulomas
• Blood tests: Glucose testing to screen for diabetes
• Differential diagnosis: Must distinguish from granuloma annulare, diabetic dermopathy

What treatment options are available?

Treatment can be challenging as the condition is often resistant:

Topical therapies:

• High-potency corticosteroids: First-line treatment, applied under occlusion
• Tacrolimus ointment: Alternative for facial lesions or steroid-resistant cases
• Topical tretinoin: May help with early lesions

Systemic treatments:

• Pentoxifylline: Improves blood flow, 400mg three times daily
• Aspirin and dipyridamole: Antiplatelet agents may help
• Systemic corticosteroids: For severe or rapidly progressive cases
• Hydroxychloroquine: May be beneficial in some patients

Other interventions:

• Intralesional corticosteroids: Injected into active borders
• Phototherapy: PUVA or narrowband UVB
• Laser therapy: Pulsed dye laser for telangiectasia
• Wound care: Important for ulcerated lesions (occurs in 35% of cases)

What is the prognosis?

The course of necrobiosis lipoidica is variable:

• Chronic course: Lesions typically persist for years
• Ulceration risk: 35% of lesions may ulcerate, particularly after trauma
• Scarring: Healed lesions often leave atrophic scars
• Diabetes relationship: Glycemic control doesn't consistently improve skin lesions
• Quality of life: Cosmetic concerns and potential for ulceration affect daily life
• Spontaneous resolution: Rare but can occur after many years

Prevention focuses on protecting affected areas from trauma, maintaining good diabetes control if present, and early treatment of new lesions. Regular monitoring is important to detect and treat complications such as ulceration promptly.